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CASE

REPORT

Lipoid proteinosis: Unfamiliar
skin findings delay diagnosis
Sydney Larkin, BA,a Elizabeth K. Blixt, MD,b Neeraj Kumar, MD,c
Robert E. Watson, Jr, MD, PhD,d Nneka I. Comfere, MD,e,f and Jennifer L. Hand, MDe,g,h
Rochester and St Cloud, Minnesota
Key words: ECM1; extracellular matrix protein; genetic skin disorders; lipoid; proteinosis; Retinoid.

INTRODUCTION
Lipoid proteinosis (LP) is a rare, inherited condition that progresses gradually with multisystemic
manifestations. Histopathologic characteristics can
be understated, delaying the diagnosis if a high
degree of suspicion is not present.

REPORT OF CASE
A 21-year-old Somalian man presented with
uncomfortable skin fragility and thickening that was
progressive since childhood. He described recurrent
asymptomatic blisters on his extremities that ruptured
and healed with scarring, reduced mobility of his
hands and feet caused by thickened palmoplantar
skin, and painful thickening of his tongue and lips.
Family history included parental consanguinity (first
cousins) and a similarly affected sister. On examination, he appeared older than his stated age and spoke
with a soft, hoarse, breathy voice. He had generalized,
diffuse wrinkling and nummular, atrophic, 6-mm to 2cm patches over his shoulders, axillae, left flank,
hands, and groin (Fig 1). His mucosal lips and tongue
were enlarged with a rugated, papillomatous texture
(Fig 1). A 5-year seizure history prompted neurologic
evaluation. Magnetic resonance imaging (MRI) found
low-signal foci centered in the amygdalae (Fig 2).
Histopathologic assessment of lesional skin in the
axilla, referred without clinical impression for LP,
was initially interpreted as nondiagnostic. Verhoff
Van Gieson stain highlighted slightly diminished,
fragmented elastic tissue fibers in the superficial
dermis. With evidence of distinctive neuroimaging
findings, there was clinical suspicion of LP. Review of
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skin biopsies found eosinophilic hyaline deposits
surrounding eccrine glandular structures. Periodic
Acid-Schiff diastase and type IV collagen immunohistochemical stains highlighted eosinophilic hyaline material (Fig 3). Cutaneous, neurologic,
radiologic, and otolaryngologic findings clinically
confirmed the diagnosis of LP. Genetic consultation
and testing of peripheral blood found confirmatory
homozygous mutations [c.580T[G; p.Phe194Val.] in
the extracellular matrix protein 1 (ECM1) gene. To
treat this patient’s mouth discomfort and reduced
hand mobility, oral acitretin was initiated. After a
daily dose of 25 mg (0.35 mg/kg) for 12 weeks, he
showed softening of his hands and feet with
increased flexibility and mobility and described
decreased soreness of his mouth and tongue.

DISCUSSION
LP is due to an ECM1 gene mutation that results in
deposition of hyaline material in the skin, mucous
membranes, and internal organs. Dermatologic manifestations such as yellow, beaded papules at the
eyelid margin (moniliform blepharosis), are often
subtle. Generalized skin thickening most commonly
affects the face and extremities.1 In areas of mechanical friction, blisters and scars can form from even
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Fig 2. Neuroimaging. Follow-up CT confirmed that the
low signal foci on the MRI showed typical bright CT
appearance of calcifications (arrow). Also, CT accentuated
some smaller bilaterally symmetric calcifications at the
adjacent parahippocampal gyri (arrowheads). This unique
imaging appearance is very suggestive of LP.

Fig 1. Signs of LP on physical examination. A, Atrophic
patches on shoulder (arrows) and fine wrinkling. B,
Diffuse thickening of the tongue causing scalloped borders and papillomatous texture.

minor trauma. A hoarse voice is typically the first and
most prominent clinical sign.2 Calcification of the
amygdalae can lead to epilepsy and neuropsychiatric
abnormalities. Characteristic calcification is evident
on MRI and is confirmed on computed tomography
(CT).3 These findings prompted further consideration
of the LP diagnosis in our patient (Fig 2).
On histopathologic evaluation, LP is characterized
by progressive eosinophilic hyaline material along
the dermoepidermal junction, blood vessels, and
adnexal structures, making it difficult to distinguish
from more diffuse dermal diseases.4-6 The distinction
between lipoid proteinosis and cutaneous amyloid
deposition is challenging in the early stages, as
hyaline eosinophilic deposits may stain with thioflavin T and weakly with Congo red in both
disorders. Further diagnosis of LP is clarified by
periodic acideSchiffepositive and diastase-resistant
staining of hyaline deposits and ultrastructural

Fig 3. Skin histopathology. Peri-eccrine eosinophilic,
hyalinelike deposition is accentuated with periodic
acideSchiff diastase reaction. (Original magnification:
3200.)

examination finding of concentric rings of basement
membrane material, reduplication of the lamina
densa at the dermoepidermal junction, and dermal
fibroblasts revealing cytoplasmic vacuole formation.6 Direct immunofluorescence studies using
antibodies to type IV and type VII collagen antibody
highlight thick bands at the dermoepidermal junction and around blood vessels that suggest hyaline
basement membrane thickening. These stains are
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not histologically diagnostic but rather supportive for
lipoid proteinosis.6
Treatment of LP is difficult with little information
available. Retinoids are found to modulate the metabolism of type IV collagen synthesis, inhibit the
proliferation of fibroblasts and type III collagen, and
decrease hyaline material and deposited collagen in
the dermis.7 Our patient had an excellent response to
acitretin, which highlights a potential role for retinoids
in the treatment of cutaneous and mucosal LP.
This case illustrates the diagnostic challenge of LP.
Cutaneous findings were subtle and nonspecific and
histopathologic features not readily apparent.
Communication of clinical suspicion for LP when
skin biopsy specimens are submitted for pathologic
review is important to ensure proper identification of
these potentially subtle, typical histopathologic features. Collaboration with providers in multiple specialties is necessary to establish this diagnosis.
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